ECMO as a bridge to heart transplantation

Eriberto Michel, Duc Thinh Pham*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter


Heart Transplantation remains the gold standard for treatment of end-stage heart failure refractory to medical management. Extracorporeal life support (ECLS) is an effective, emergent therapy for patient who are suffering from end-stage heart failure refractory to medical management in the setting of the nationwide shortage in donor organs. The use of ECLS has increased over time in United States as well as the evidence that this modality can be employed as a bridge to decision, bridge to recovery, bridge to durable left ventricular assist device and orthotopic heart transplantation in a select group of patients [1, 2]. In this chapter we will further explore ECLS, specifically veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) as a bridge to orthotopic heart transplantation. We will discuss patient selection, timing of support, management and outcomes.

Original languageEnglish (US)
Title of host publicationExtracorporeal Membrane Oxygenation
Subtitle of host publicationTypes, Medical Uses and Complications
PublisherNova Science Publishers, Inc.
Number of pages7
ISBN (Electronic)9781536190649
StatePublished - Dec 21 2020

ASJC Scopus subject areas

  • Medicine(all)
  • Health Professions(all)


Dive into the research topics of 'ECMO as a bridge to heart transplantation'. Together they form a unique fingerprint.

Cite this